ARMISTICE CAPITAL, LLC purchased 0.5% of their position (226K shares) of AVALO THERAPEUTICS, INC. on the open market
Open‑market purchase worth $151.9K — a small addition. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 3/14/2022ACC: 0000899243-22-010904
Director10% Owner
Since Jun 2018
+226K
Net shares
Net buyer
$151.9K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
226K acquired
Non-Derivative Transactions3
Common Stock
Indirect
Shares
+26K
Price / share
$0.70
Trade value
$18.23K
% of position
0.1%
3/10/2022
47.35M→47.38M
Common Stock
Indirect
Shares
+100K
Price / share
$0.69
Trade value
$68.78K
% of position
0.2%
3/11/2022
47.38M→47.48M
Common Stock
Indirect
Shares
+100K
Price / share
$0.65
Trade value
$64.94K
% of position
0.2%
3/14/2022
47.48M→47.58M
Total
Net shares
+226K
Net value
$151.95K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 3/10/2022 | P · Purchase | +26K | $0.70 | $18.23K | 0.1% | 47.35M | 47.38M |
| Common Stock Indirect | 3/11/2022 | P · Purchase | +100K | $0.69 | $68.78K | 0.2% | 47.38M | 47.48M |
| Common Stock Indirect | 3/14/2022 | P · Purchase | +100K | $0.65 | $64.94K | 0.2% | 47.48M | 47.58M |
| Total | +226K | $151.95K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned412.44K
Total
412.44K direct412.44K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 412.44K | Direct |
| Total | 412.44K | 412.44K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported